Financials
Financial year 2025
MediDeferm from Begijnendijk, company number BE1012361086, closed financial year 2025 with a result of € 216,352 after tax. For that financial year MediDeferm recorded a gross margin of € 284,829 and equity of € 209,822. Compared with financial year 2024, the result moved from € -9,530 to € 216,352. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 2, 2026.
€ 209,822
▲ € 216,352 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 216,352
▲ still € 9,530 loss in 2024
Profit after tax over the fiscal year.
€ 219,873
▲ € 219,122 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 206,822.
People and assets in 2025
€ 1,531
▼ 22% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,099
▼ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 69,429
▲ € 68,653 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € -9,072 | € 284,829 | ▲ € 293,901 |
| Profit after taxes | € -9,530 | € 216,352 | ▲ € 225,881 |
| Equity | € -6,530 | € 209,822 | ▲ € 216,352 |
| Total debts | € 10,518 | € 70,528 | ▲ € 60,009 |
| Cash | € 751 | € 219,873 | ▲ € 219,122 |
| Retained profit | € -9,530 | € 206,822 | ▲ € 216,352 |
| Balance sheet total | € 3,989 | € 280,350 | ▲ € 276,361 |
Key figures of MediDeferm, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about MediDeferm the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to MediDeferm?
What happened at MediDeferm in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 216,352. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Begijnendijk. KBO
- Sébastien Deferm became a director. NBB
In short
From € 9,530 loss in 2024 to € 216,352 profit in 2025.
Paid € 66,846 in corporate taxes since 2024.
Best year ever: 2025, with € 216,352 profit.
Management
Behind MediDeferm is Sébastien Deferm.
Directors
According to the 2025 annual accounts
Sébastien Deferm
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Werchtersesteenweg 58
3130 Begijnendijk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- DEFERM Sébastien(oprichter) 100%
Details
- Company number
- 1012.361.086
- VAT number
- BE 1012.361.086
- Registered office
- Werchtersesteenweg 58, 3130 Begijnendijk
- Names & denominations
- MediDeferm
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 August 2024
- Peppol
- Active · Active since 12 Jul 2025
- Activities · NACE
Activiteiten van medisch specialisten
Overige zakelijke dienstverlening, neg